Abingworth

Chicago, Illinois
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciencessectors. Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions.
Founded:1973
Firm Location:Chicago, Illinois • San Francisco, California • Boston, Massachusetts • Menlo Park, California • London
Abingworth Team
Photo of Scott Brun, Venture Partner at Abingworth
Scott Brun
Abingworth·Venture Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Boston (MA)
Photo of Lucille Conroy, Principal at Abingworth
Lucille Conroy
Abingworth·Principal
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in United Kingdom, Investors in London
Photo of Jay Cui, Principal at Abingworth
Jay Cui
Abingworth·Principal
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Menlo Park (CA)
Photo of Kurt von Emster, Managing Partner at Abingworth
Kurt von Emster
Abingworth·Managing Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Menlo Park (CA)
Photo of Brian Gallagher, Partner at Abingworth
Brian Gallagher
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Jacqueline Grant, Principal at Abingworth
Jacqueline Grant
Abingworth·Principal
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Boston (MA)
Photo of Ken Haas, Investor at Abingworth
Ken Haas
Abingworth·Investor
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in San Francisco (CA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Timothy Haines, Managing Partner at Abingworth
Timothy Haines
Abingworth·Managing Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Genghis Lloyd-Harris, Partner at Abingworth
Genghis Lloyd-Harris
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Photo of Diya Malhotra, Investor at Abingworth
Diya Malhotra
Abingworth·Investor
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Vincent Miles, Partner at Abingworth
Vincent Miles
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in Boston (MA)
Photo of Bali Muralidhar, Managing Partner at Abingworth
Bali Muralidhar
Abingworth·Managing Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Photo of Jayson Punwani, Partner at Abingworth
Jayson Punwani
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in SF Bay Area (CA)
Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in San Francisco Bay Area (Other Lists)
Photo of Andrew Sinclair, Partner at Abingworth
Andrew Sinclair
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)